Navigation Links
Failure of 'scout cells' may lead to cancer in transplant patients

A serious form of cancer that occurs in some transplant patients may arise because cells that normally serve as scouts for the immune system become weakened, a new study suggests.

The cancer is caused by Epstein-Barr virus (EBV), a herpesvirus that infects more than 90 percent of Americans but is ordinarily kept under control by the immune system. That control can be lost in people whose immune system is suppressed to prevent rejection of a transplanted organ.

The cancer, called post-transplant lymphoproliferative disorder (PTLD), arises only in some transplant patients, but doctors don't know why.

This study, led by Ohio State University scientists, begins to answer that question.

The findings are published in the August issue of the American Journal of Transplantation.

We've identified a mechanism that may explain why some patients develop PTLD and others don't, says study leader Anne M. VanBuskirk, assistant professor of surgery and an OSU Comprehensive Cancer Center researcher.

If we can understand the mechanism, perhaps we can discover how to prevent this type of cancer in transplant patients.

The incidence of this cancer varies according to the organ transplanted, occurring in 1 to 2 percent of kidney transplant patients and in up to 20 percent of bone marrow and lung transplant patients. The disease usually arises within six months to a year after transplantation, and it can have a 70- to 80-percent mortality rate.

The study by VanBuskirk and her colleagues examines two types of immune cells: cells that act as scouts scientists call them antigen-presenting cells and memory T cells.

Scout cells detect the presence of viruses and other invaders and alert the immune system to the infection. Memory T cells are immune cells that have fought an earlier infection and remain ready to respond quickly should that infection occur again.

Most people are infected by EBV earl y in life and the immune system brings it under control, although the virus remains hidden in some cells of the body. If the infection flares up again, scout cells alert the memory T cells, which rapidly proliferate and hunt down and kill any cells that contain growing virus or have become cancerous.

If memory T cells are re-stimulated properly, they can kill the cancerous cells before PTLD develops, VanBuskirk says. But if that re-stimulation is weak or is blocked, not all of the cells are destroyed and cancer can develop. So it is critical that these two cell types work together effectively.

The present study suggests that PTLD arises because the scout cells can only weakly activate the memory T cells and stop their activation by other cells.

VanBuskirk and her team believe this happens because an immune-system substance causes changes in the scout cells, inhibiting their ability to warn memory T cells about the virus. That substance is called transforming growth factor-beta (TGFb).

The researchers discovered this by exposing healthy human scout cells to TGFb. Next, they combined the scout cells with T cells and PTLD-like cancer cells.

The T cells that grew alongside the scout cells exposed to TGFb were significantly less able to kill the cancer cells than were the T cells growing with scout cells not exposed to TGFb.

In addition, when scout cells from both groups were combined, the TGFb-exposed cells were stronger and prevented the unexposed scout cells from re-stimulating the memory T cells.

The present study follows earlier research led by VanBuskirk that suggests why only some transplant patients develop PTLD and not others.

The earlier study, published in a February 2005 issue of the journal Blood, suggested that the balance in the body of TGFb and a second immune substance called interferon gamma (IFNg) might influence development of the cancer.

The study showed that so me people have a normal genetic difference that causes them to have lower levels of IFNg in the body and others to have higher levels.

The researchers then injected white blood cells from each of the two groups of people into immune-deficient mice. All the people were healthy and tested positive for EBV.

They found that white blood cells from people who had the genetic difference for lower IFNgÆ’nlevels were more likely to cause EBV-related cancer in the mice than cells from people with the genetic difference for higher IFNg levels. They also found that blocking TGFb prevented the EBV-related cancer.

We hypothesize that the balance between IFNgÆ’nand TGFb is probably important in determining whether or not the cancer develops, VanBuskirk says.

In the new study, for example, adding IFNg to TGFb prevented the scout cells from changing and allowed them to strongly re-stimulate the memory T cells.

If our hypothesis proves to be true, VanBuskirk says, it may one day be possible to identify transplant patients who are at greater risk for PTLD and to develop new therapies that prevent or treat the disease.


'"/>

Source:Ohio State University


Related biology news :

1. Implanted Devices Detect High-Risk Heart Failure Patients
2. Newly Discovered Role for Heart Response Enzyme May Yield Better Heart Failure Therapy
3. Failure to meet United Nations sanitation target could affect millions of the worlds poorest
4. Two chemicals boost immune cells ability to fight HIV without gene therapy
5. Once given no respect, cells tiny RNAS take drivers seat
6. How HIV disables the cells call for help
7. Stem cells electric abilities might help their safe clinical use
8. Scientists discover the molecular switch for nerve cells insulating jelly rolls
9. New insight into machinery of immune cells tentacles
10. Allergy cells can aggravate cancer and psoriasis
11. A key antibody, IgG, links cells capture and disposal of germs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/28/2016)... 2016 "The biometric system ... The biometric system market is in the growth ... near future. The biometric system market is expected to ... a CAGR of 16.79% between 2016 and 2022. Government ... technology in smartphones, rising use of biometric technology in ...
(Date:11/22/2016)... According to the new market research report "Biometric System Market ... Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, and Region ... to grow from USD 10.74 Billion in 2015 to reach USD 32.73 ... Continue Reading ... ...
(Date:11/21/2016)... Nov. 21, 2016   Neurotechnology , a ... technologies, today announced that the MegaMatcher On Card ... submitted for the NIST Minutiae Interoperability Exchange ... the mandatory steps of the evaluation protocol. ... continuing test of fingerprint templates used to establish ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... , Dec. 7, 2016  Biocom, the association for ... the statement below following passage of 21 st Century ... on November 30 by a 392-26 vote and in the ... may be attributed to Joe Panetta , president & ... that will give hope to millions of patients around the ...
(Date:12/7/2016)... ANN ARBOR, Mich. , Dec. 7, ... developing breakthrough immune modulatory medicines, announced today the initiation ... lead therapeutic candidate, LYC-30937- E nteric C oated, ... skin disease that is estimated to affect as many ... , with approximately 1.5 - 3 million cases ...
(Date:12/7/2016)... , ... December 07, 2016 ... ... opening applications to an early access program for SmartBiome -- a novel ... with the simultaneous specific enrichment and detection of hundreds of different genes. ...
(Date:12/6/2016)... ... December 06, 2016 , ... The Osteoarthritis Research ... Federal Drug Administration (FDA) to consider OA as a serious disease. As an ... the growing population of OA patients, many of whom may experience progressive disability ...
Breaking Biology Technology: